Clinical evaluation of Siddha drug Sanmuga mezhugu in low back ache (sciatica).
Phase 2
- Conditions
- Health Condition 1: M543- Sciatica
- Registration Number
- CTRI/2019/08/020779
- Lead Sponsor
- Government Siddha medical college
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients having pain in the low back or leg
Burning or tingling sensation present in the posterior and lateral aspect of the leg
Weakness, numbness and difficulty in moving the leg or foot
A constant pain on one side of the back
A positive SLR test
Exclusion Criteria
Fracture of vertebrae
Dislocation of vertebrae
Deformities and congenital defects
Known case of tuberculosis of spine
Known case of neoplasm of spine
Pregnancy and lactating women
Multiple myeloma
Patients of age below 25 above 60 years
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome of treatment is mainly assessed by reduction in clinical symptoms measured by using Roland-Morris disability scaleTimepoint: 35 days with intermittent 7 days gap
- Secondary Outcome Measures
Name Time Method Secondary outcome of treatment is assessed by comparing the safety parameters before and after treatmentTimepoint: 35 days with intermittent 7 days gap